2018
DOI: 10.1159/000493963
|View full text |Cite
|
Sign up to set email alerts
|

Gq-Induced Apoptosis is Mediated by AKT Inhibition That Leads to PKC-Induced JNK Activation

Abstract: Background/Aims: Gq protein-coupled receptors (GqPCRs) regulate various cellular processes including mainly proliferation and differentiation. In a previous study, we found that in prostate cancer cells, the GqPCR of GnRH induces apoptosis by reducing the PKC-dependent AKT activity and elevating JNK phosphorylation. Since it was thought that GqPCR induces mainly activation of AKT, we undertook to examine how general is this phenomenon and understand its signaling. Methods: We used various cells to follow the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
25
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(29 citation statements)
references
References 53 publications
(74 reference statements)
4
25
0
Order By: Relevance
“…Because a selective JNK inhibitor, SP600125, inhibited cytokine-induced cytotoxicity in a dose-dependent manner, JNK/c-Jun pathway can be a pharmacological target in alleviating inflammation-induced alveolar epithelial injury. It is well established that JNK/c-Jun pathway is strongly associated with apoptosis [29, 30]. In fact, because co-treatment with dexamethasone and rapamycin augmented the inhibition of c-Jun phosphorylation, the synergistic cytoprotective effect would be, at least partially, derived from the inhibition of JNK/c-Jun pathway.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Because a selective JNK inhibitor, SP600125, inhibited cytokine-induced cytotoxicity in a dose-dependent manner, JNK/c-Jun pathway can be a pharmacological target in alleviating inflammation-induced alveolar epithelial injury. It is well established that JNK/c-Jun pathway is strongly associated with apoptosis [29, 30]. In fact, because co-treatment with dexamethasone and rapamycin augmented the inhibition of c-Jun phosphorylation, the synergistic cytoprotective effect would be, at least partially, derived from the inhibition of JNK/c-Jun pathway.…”
Section: Discussionmentioning
confidence: 99%
“…Augmentation of Akt activity by co-treatment with dexamethasone and rapamycin is also a very promising observation. Akt is well known as a primary molecule in survival signal pathways [29, 31], so it is probable that Akt also contributes to cell survival under cytokine stimulation. To clarify this point, we performed an additional experiment, wherein we checked whether the inhibition of Akt using a PI-3K inhibitor, LY294002, could cancel cytoprotection induced by dexamethasone and rapamycin.…”
Section: Discussionmentioning
confidence: 99%
“…GnRH-R activation was further reported to be associated with proapoptotic effects [ 175 , 176 ]. In particular, in CRPC cells, GnRH agonists were shown to trigger apoptosis-related molecular events through the down-regulation of the PI3K/AKT signaling pathway, leading to the activation of the downstream JNK kinase, and MEK/ERK kinase activity [ 177 , 178 ].…”
Section: The Gnrh/gnrh-r Axis In Crpcmentioning
confidence: 99%
“…In line with these observations, cleaved caspase-8 and -3, but not -9, and increased expression and phosphorylation of p53, were reported to increase in primary cell cultures from human PCa samples, supporting the idea that the extrinsic (but not intrinsic) apoptosis pathway is involved in the antitumor activity of GnRH agonists [ 171 , 173 , 180 , 181 ]. The different cell context-dependent biological effects of GnRH agonists at the pituitary vs. PCa cell level was suggested to be related to a transient vs. sustained activation of the intracellular signaling pathway (PKC/MAPK) in gonadotropes vs. cancer cells [ 176 , 182 ].…”
Section: The Gnrh/gnrh-r Axis In Crpcmentioning
confidence: 99%
See 1 more Smart Citation